STONKWHISPER
← Back to Intel
Insider ActivitySYRE

Turtle Cameron, Chief Executive Officer, Director at Spyre Therapeutics, Inc., sold $126K of SYRE

Updated Jun 14, 2026
Turtle Cameron Chief Executive Officer, Director
Spyre Therapeutics, Inc. · $SYRE
$126K Total Value
1,700 Shares Traded
$74.23 Price / Share
612,840 Shares Owned After
2026-05-01 Filing Date

Transaction Details

InsiderTurtle Cameron
TitleChief Executive Officer, Director
CompanySpyre Therapeutics, Inc.
TickerSYRE
Transaction TypeSale
Transaction Date2026-05-01
Shares Traded1,700
Price Per Share$74.23
Total Value$126K
Filed Date2026-05-01
Accession Number0001758363-26-000009

Ownership Context

Shares Owned After Transaction612,840
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001758363-26-000009

Other Insider Trades — SYRE

Other Trades by Turtle Cameron

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for SYRE — Spyre Therapeutics, Inc. →

Track SYRE insider activity in real time on The Wire →

Get alerts when Turtle Cameron files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 14, 2026 at 07:14 UTC

Want real-time data? Access The Wire for live sentiment tracking.